Tyler E. Miller, MD, PhD
Tyler E. Miller, MD, PhD
Department of Pathology, Massachusetts General Hospital, Boston, MA
Verified email at mgh.harvard.edu
Title
Cited by
Cited by
Year
MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1
TE Miller, K Ghoshal, B Ramaswamy, S Roy, J Datta, CL Shapiro, S Jacob, ...
Journal of biological chemistry 283 (44), 29897-29903, 2008
8182008
Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo
FJ Najm, M Madhavan, A Zaremba, E Shick, RT Karl, DC Factor, TE Miller, ...
Nature 522 (7555), 216-220, 2015
2592015
Adaptive chromatin remodeling drives glioblastoma stem cell plasticity and drug tolerance
BB Liau, C Sievers, LK Donohue, SM Gillespie, WA Flavahan, TE Miller, ...
Cell stem cell 20 (2), 233-246. e7, 2017
1702017
Brain tumor stem cells: Molecular characteristics and their impact on therapy
DL Schonberg, D Lubelski, TE Miller, JN Rich
Molecular aspects of medicine 39, 82-101, 2014
1512014
Targeting glioma stem cells through combined BMI1 and EZH2 inhibition
X Jin, LJY Kim, Q Wu, LC Wallace, BC Prager, T Sanvoranart, RC Gimple, ...
Nature medicine 23 (11), 1352-1361, 2017
1492017
Preferential iron trafficking characterizes glioblastoma stem-like cells
DL Schonberg, TE Miller, Q Wu, WA Flavahan, NK Das, JS Hale, ...
Cancer cell 28 (4), 441-455, 2015
1402015
Anti-microRNA-222 (anti-miR-222) and-181B suppress growth of tamoxifen-resistant xenografts in mouse by targeting TIMP3 protein and modulating mitogenic signal
Y Lu, S Roy, G Nuovo, B Ramaswamy, T Miller, C Shapiro, ST Jacob, ...
Journal of Biological Chemistry 286 (49), 42292-42302, 2011
1022011
Transcription elongation factors represent in vivo cancer dependencies in glioblastoma
TE Miller, BB Liau, LC Wallace, AR Morton, Q Xie, D Dixit, DC Factor, ...
Nature 547 (7663), 355-359, 2017
1012017
Myosin II isoform switching mediates invasiveness after TGF-β–induced epithelial–mesenchymal transition
JR Beach, GS Hussey, TE Miller, A Chaudhury, P Patel, J Monslow, ...
Proceedings of the National Academy of Sciences 108 (44), 17991-17996, 2011
972011
Therapeutic targeting of ependymoma as informed by oncogenic enhancer profiling
SC Mack, KW Pajtler, L Chavez, K Okonechnikov, KC Bertrand, X Wang, ...
Nature 553 (7686), 101-105, 2018
902018
Reciprocal signaling between glioblastoma stem cells and differentiated tumor cells promotes malignant progression
X Wang, BC Prager, Q Wu, LJY Kim, RC Gimple, Y Shi, K Yang, ...
Cell stem cell 22 (4), 514-528. e5, 2018
812018
An epigenetic gateway to brain tumor cell identity
SC Mack, CG Hubert, TE Miller, MD Taylor, JN Rich
Nature neuroscience 19 (1), 10-19, 2016
732016
N6-methyladenine DNA modification in glioblastoma
Q Xie, TP Wu, RC Gimple, Z Li, BC Prager, Q Wu, Y Yu, P Wang, Y Wang, ...
Cell 175 (5), 1228-1243. e20, 2018
722018
Purine synthesis promotes maintenance of brain tumor initiating cells in glioma
X Wang, K Yang, Q Xie, Q Wu, SC Mack, Y Shi, LJY Kim, BC Prager, ...
Nature neuroscience 20 (5), 661-673, 2017
582017
Lineage-specific splicing of a brain-enriched alternative exon promotes glioblastoma progression
R Ferrarese, GR Harsh, AK Yadav, E Bug, D Maticzka, W Reichardt, ...
The Journal of clinical investigation 124 (7), 2861-2876, 2014
582014
Positively selected enhancer elements endow osteosarcoma cells with metastatic competence
JJ Morrow, I Bayles, APW Funnell, TE Miller, A Saiakhova, MM Lizardo, ...
Nature medicine 24 (2), 176, 2018
502018
Methylation of histone H3 and H4 by PRMT5 regulates ribosomal RNA gene transcription
S Majumder, L Alinari, S Roy, T Miller, J Datta, S Sif, R Baiocchi, ST Jacob
Journal of cellular biochemistry 109 (3), 553-563, 2010
502010
MYC-regulated mevalonate metabolism maintains brain tumor–initiating cells
X Wang, Z Huang, Q Wu, BC Prager, SC Mack, K Yang, LJY Kim, ...
Cancer research 77 (18), 4947-4960, 2017
452017
Upregulation of glucose-regulated protein 78 in metastatic cancer cells is necessary for lung metastasis progression
MM Lizardo, JJ Morrow, TE Miller, ES Hong, L Ren, A Mendoza, ...
Neoplasia 18 (11), 699-710, 2016
322016
RBPJ maintains brain tumor–initiating cells through CDK9-mediated transcriptional elongation
Q Xie, Q Wu, L Kim, TE Miller, BB Liau, SC Mack, K Yang, DC Factor, ...
The Journal of clinical investigation 126 (7), 2757-2772, 2016
322016
The system can't perform the operation now. Try again later.
Articles 1–20